 | • レポートコード：QFJ1-4515 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、子宮内膜癌分子診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（PCR、FISH、DNAシーケンシング、ジーンチップ）、用途別市場規模（臨床診断、薬物スクリーニング、研究）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・子宮内膜癌分子診断の市場動向 ・企業の競争状況、市場シェア ・子宮内膜癌分子診断の種類別市場規模と予測2016-2027（PCR、FISH、DNAシーケンシング、ジーンチップ） ・子宮内膜癌分子診断の用途別市場規模と予測2016-2027（臨床診断、薬物スクリーニング、研究） ・子宮内膜癌分子診断の北米市場規模2016-2027（アメリカ、カナダ） ・子宮内膜癌分子診断の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・子宮内膜癌分子診断のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・子宮内膜癌分子診断の中南米市場規模2016-2027（メキシコ、ブラジル） ・子宮内膜癌分子診断の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Inmedi、United Gene Group、Topgen、Gene+、Sanvalley、BGHDL、Homey Health） ・結論 |
A method for diagnosing endometrial carcinoma
Market Analysis and Insights: Global Molecular Diagnosis of Endometrial Carcinoma Market
The global Molecular Diagnosis of Endometrial Carcinoma market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Molecular Diagnosis of Endometrial Carcinoma market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Molecular Diagnosis of Endometrial Carcinoma market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Molecular Diagnosis of Endometrial Carcinoma market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Molecular Diagnosis of Endometrial Carcinoma market.
Global Molecular Diagnosis of Endometrial Carcinoma Scope and Market Size
Molecular Diagnosis of Endometrial Carcinoma market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Molecular Diagnosis of Endometrial Carcinoma market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
PCR
FISH
DNA Sequencing
Gene Chip
Segment by Application
Clinical Diagnosis
Drug Screening
Research
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Inmedi
United Gene Group
Topgen
Gene+
Sanvalley
BGHDL
Homey Health
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Molecular Diagnosis of Endometrial Carcinoma Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 PCR
1.2.3 FISH
1.2.4 DNA Sequencing
1.2.5 Gene Chip
1.3 Market by Application
1.3.1 Global Molecular Diagnosis of Endometrial Carcinoma Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Clinical Diagnosis
1.3.3 Drug Screening
1.3.4 Research
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Molecular Diagnosis of Endometrial Carcinoma Market Perspective (2016-2027)
2.2 Molecular Diagnosis of Endometrial Carcinoma Growth Trends by Regions
2.2.1 Molecular Diagnosis of Endometrial Carcinoma Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Molecular Diagnosis of Endometrial Carcinoma Historic Market Share by Regions (2016-2021)
2.2.3 Molecular Diagnosis of Endometrial Carcinoma Forecasted Market Size by Regions (2022-2027)
2.3 Molecular Diagnosis of Endometrial Carcinoma Industry Dynamic
2.3.1 Molecular Diagnosis of Endometrial Carcinoma Market Trends
2.3.2 Molecular Diagnosis of Endometrial Carcinoma Market Drivers
2.3.3 Molecular Diagnosis of Endometrial Carcinoma Market Challenges
2.3.4 Molecular Diagnosis of Endometrial Carcinoma Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Molecular Diagnosis of Endometrial Carcinoma Players by Revenue
3.1.1 Global Top Molecular Diagnosis of Endometrial Carcinoma Players by Revenue (2016-2021)
3.1.2 Global Molecular Diagnosis of Endometrial Carcinoma Revenue Market Share by Players (2016-2021)
3.2 Global Molecular Diagnosis of Endometrial Carcinoma Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Molecular Diagnosis of Endometrial Carcinoma Revenue
3.4 Global Molecular Diagnosis of Endometrial Carcinoma Market Concentration Ratio
3.4.1 Global Molecular Diagnosis of Endometrial Carcinoma Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Molecular Diagnosis of Endometrial Carcinoma Revenue in 2020
3.5 Molecular Diagnosis of Endometrial Carcinoma Key Players Head office and Area Served
3.6 Key Players Molecular Diagnosis of Endometrial Carcinoma Product Solution and Service
3.7 Date of Enter into Molecular Diagnosis of Endometrial Carcinoma Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Molecular Diagnosis of Endometrial Carcinoma Breakdown Data by Type
4.1 Global Molecular Diagnosis of Endometrial Carcinoma Historic Market Size by Type (2016-2021)
4.2 Global Molecular Diagnosis of Endometrial Carcinoma Forecasted Market Size by Type (2022-2027)
5 Molecular Diagnosis of Endometrial Carcinoma Breakdown Data by Application
5.1 Global Molecular Diagnosis of Endometrial Carcinoma Historic Market Size by Application (2016-2021)
5.2 Global Molecular Diagnosis of Endometrial Carcinoma Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Molecular Diagnosis of Endometrial Carcinoma Market Size (2016-2027)
6.2 North America Molecular Diagnosis of Endometrial Carcinoma Market Size by Type
6.2.1 North America Molecular Diagnosis of Endometrial Carcinoma Market Size by Type (2016-2021)
6.2.2 North America Molecular Diagnosis of Endometrial Carcinoma Market Size by Type (2022-2027)
6.2.3 North America Molecular Diagnosis of Endometrial Carcinoma Market Size by Type (2016-2027)
6.3 North America Molecular Diagnosis of Endometrial Carcinoma Market Size by Application
6.3.1 North America Molecular Diagnosis of Endometrial Carcinoma Market Size by Application (2016-2021)
6.3.2 North America Molecular Diagnosis of Endometrial Carcinoma Market Size by Application (2022-2027)
6.3.3 North America Molecular Diagnosis of Endometrial Carcinoma Market Size by Application (2016-2027)
6.4 North America Molecular Diagnosis of Endometrial Carcinoma Market Size by Country
6.4.1 North America Molecular Diagnosis of Endometrial Carcinoma Market Size by Country (2016-2021)
6.4.2 North America Molecular Diagnosis of Endometrial Carcinoma Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Molecular Diagnosis of Endometrial Carcinoma Market Size (2016-2027)
7.2 Europe Molecular Diagnosis of Endometrial Carcinoma Market Size by Type
7.2.1 Europe Molecular Diagnosis of Endometrial Carcinoma Market Size by Type (2016-2021)
7.2.2 Europe Molecular Diagnosis of Endometrial Carcinoma Market Size by Type (2022-2027)
7.2.3 Europe Molecular Diagnosis of Endometrial Carcinoma Market Size by Type (2016-2027)
7.3 Europe Molecular Diagnosis of Endometrial Carcinoma Market Size by Application
7.3.1 Europe Molecular Diagnosis of Endometrial Carcinoma Market Size by Application (2016-2021)
7.3.2 Europe Molecular Diagnosis of Endometrial Carcinoma Market Size by Application (2022-2027)
7.3.3 Europe Molecular Diagnosis of Endometrial Carcinoma Market Size by Application (2016-2027)
7.4 Europe Molecular Diagnosis of Endometrial Carcinoma Market Size by Country
7.4.1 Europe Molecular Diagnosis of Endometrial Carcinoma Market Size by Country (2016-2021)
7.4.2 Europe Molecular Diagnosis of Endometrial Carcinoma Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Molecular Diagnosis of Endometrial Carcinoma Market Size (2016-2027)
8.2 Asia-Pacific Molecular Diagnosis of Endometrial Carcinoma Market Size by Type
8.2.1 Asia-Pacific Molecular Diagnosis of Endometrial Carcinoma Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Molecular Diagnosis of Endometrial Carcinoma Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Molecular Diagnosis of Endometrial Carcinoma Market Size by Type (2016-2027)
8.3 Asia-Pacific Molecular Diagnosis of Endometrial Carcinoma Market Size by Application
8.3.1 Asia-Pacific Molecular Diagnosis of Endometrial Carcinoma Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Molecular Diagnosis of Endometrial Carcinoma Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Molecular Diagnosis of Endometrial Carcinoma Market Size by Application (2016-2027)
8.4 Asia-Pacific Molecular Diagnosis of Endometrial Carcinoma Market Size by Region
8.4.1 Asia-Pacific Molecular Diagnosis of Endometrial Carcinoma Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Molecular Diagnosis of Endometrial Carcinoma Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Molecular Diagnosis of Endometrial Carcinoma Market Size (2016-2027)
9.2 Latin America Molecular Diagnosis of Endometrial Carcinoma Market Size by Type
9.2.1 Latin America Molecular Diagnosis of Endometrial Carcinoma Market Size by Type (2016-2021)
9.2.2 Latin America Molecular Diagnosis of Endometrial Carcinoma Market Size by Type (2022-2027)
9.2.3 Latin America Molecular Diagnosis of Endometrial Carcinoma Market Size by Type (2016-2027)
9.3 Latin America Molecular Diagnosis of Endometrial Carcinoma Market Size by Application
9.3.1 Latin America Molecular Diagnosis of Endometrial Carcinoma Market Size by Application (2016-2021)
9.3.2 Latin America Molecular Diagnosis of Endometrial Carcinoma Market Size by Application (2022-2027)
9.3.3 Latin America Molecular Diagnosis of Endometrial Carcinoma Market Size by Application (2016-2027)
9.4 Latin America Molecular Diagnosis of Endometrial Carcinoma Market Size by Country
9.4.1 Latin America Molecular Diagnosis of Endometrial Carcinoma Market Size by Country (2016-2021)
9.4.2 Latin America Molecular Diagnosis of Endometrial Carcinoma Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Molecular Diagnosis of Endometrial Carcinoma Market Size (2016-2027)
10.2 Middle East & Africa Molecular Diagnosis of Endometrial Carcinoma Market Size by Type
10.2.1 Middle East & Africa Molecular Diagnosis of Endometrial Carcinoma Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Molecular Diagnosis of Endometrial Carcinoma Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Molecular Diagnosis of Endometrial Carcinoma Market Size by Type (2016-2027)
10.3 Middle East & Africa Molecular Diagnosis of Endometrial Carcinoma Market Size by Application
10.3.1 Middle East & Africa Molecular Diagnosis of Endometrial Carcinoma Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Molecular Diagnosis of Endometrial Carcinoma Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Molecular Diagnosis of Endometrial Carcinoma Market Size by Application (2016-2027)
10.4 Middle East & Africa Molecular Diagnosis of Endometrial Carcinoma Market Size by Country
10.4.1 Middle East & Africa Molecular Diagnosis of Endometrial Carcinoma Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Molecular Diagnosis of Endometrial Carcinoma Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Inmedi
11.1.1 Inmedi Company Details
11.1.2 Inmedi Business Overview
11.1.3 Inmedi Molecular Diagnosis of Endometrial Carcinoma Introduction
11.1.4 Inmedi Revenue in Molecular Diagnosis of Endometrial Carcinoma Business (2016-2021)
11.1.5 Inmedi Recent Development
11.2 United Gene Group
11.2.1 United Gene Group Company Details
11.2.2 United Gene Group Business Overview
11.2.3 United Gene Group Molecular Diagnosis of Endometrial Carcinoma Introduction
11.2.4 United Gene Group Revenue in Molecular Diagnosis of Endometrial Carcinoma Business (2016-2021)
11.2.5 United Gene Group Recent Development
11.3 Topgen
11.3.1 Topgen Company Details
11.3.2 Topgen Business Overview
11.3.3 Topgen Molecular Diagnosis of Endometrial Carcinoma Introduction
11.3.4 Topgen Revenue in Molecular Diagnosis of Endometrial Carcinoma Business (2016-2021)
11.3.5 Topgen Recent Development
11.4 Gene+
11.4.1 Gene+ Company Details
11.4.2 Gene+ Business Overview
11.4.3 Gene+ Molecular Diagnosis of Endometrial Carcinoma Introduction
11.4.4 Gene+ Revenue in Molecular Diagnosis of Endometrial Carcinoma Business (2016-2021)
11.4.5 Gene+ Recent Development
11.5 Sanvalley
11.5.1 Sanvalley Company Details
11.5.2 Sanvalley Business Overview
11.5.3 Sanvalley Molecular Diagnosis of Endometrial Carcinoma Introduction
11.5.4 Sanvalley Revenue in Molecular Diagnosis of Endometrial Carcinoma Business (2016-2021)
11.5.5 Sanvalley Recent Development
11.6 BGHDL
11.6.1 BGHDL Company Details
11.6.2 BGHDL Business Overview
11.6.3 BGHDL Molecular Diagnosis of Endometrial Carcinoma Introduction
11.6.4 BGHDL Revenue in Molecular Diagnosis of Endometrial Carcinoma Business (2016-2021)
11.6.5 BGHDL Recent Development
11.7 Homey Health
11.7.1 Homey Health Company Details
11.7.2 Homey Health Business Overview
11.7.3 Homey Health Molecular Diagnosis of Endometrial Carcinoma Introduction
11.7.4 Homey Health Revenue in Molecular Diagnosis of Endometrial Carcinoma Business (2016-2021)
11.7.5 Homey Health Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Molecular Diagnosis of Endometrial Carcinoma Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of PCR
Table 3. Key Players of FISH
Table 4. Key Players of DNA Sequencing
Table 5. Key Players of Gene Chip
Table 6. Global Molecular Diagnosis of Endometrial Carcinoma Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Molecular Diagnosis of Endometrial Carcinoma Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Molecular Diagnosis of Endometrial Carcinoma Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Molecular Diagnosis of Endometrial Carcinoma Market Share by Regions (2016-2021)
Table 10. Global Molecular Diagnosis of Endometrial Carcinoma Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Molecular Diagnosis of Endometrial Carcinoma Market Share by Regions (2022-2027)
Table 12. Molecular Diagnosis of Endometrial Carcinoma Market Trends
Table 13. Molecular Diagnosis of Endometrial Carcinoma Market Drivers
Table 14. Molecular Diagnosis of Endometrial Carcinoma Market Challenges
Table 15. Molecular Diagnosis of Endometrial Carcinoma Market Restraints
Table 16. Global Molecular Diagnosis of Endometrial Carcinoma Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Molecular Diagnosis of Endometrial Carcinoma Market Share by Players (2016-2021)
Table 18. Global Top Molecular Diagnosis of Endometrial Carcinoma Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Molecular Diagnosis of Endometrial Carcinoma as of 2020)
Table 19. Ranking of Global Top Molecular Diagnosis of Endometrial Carcinoma Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Molecular Diagnosis of Endometrial Carcinoma Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Molecular Diagnosis of Endometrial Carcinoma Product Solution and Service
Table 23. Date of Enter into Molecular Diagnosis of Endometrial Carcinoma Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Molecular Diagnosis of Endometrial Carcinoma Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Molecular Diagnosis of Endometrial Carcinoma Revenue Market Share by Type (2016-2021)
Table 27. Global Molecular Diagnosis of Endometrial Carcinoma Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Molecular Diagnosis of Endometrial Carcinoma Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Molecular Diagnosis of Endometrial Carcinoma Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Molecular Diagnosis of Endometrial Carcinoma Revenue Market Share by Application (2016-2021)
Table 31. Global Molecular Diagnosis of Endometrial Carcinoma Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Molecular Diagnosis of Endometrial Carcinoma Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Molecular Diagnosis of Endometrial Carcinoma Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Molecular Diagnosis of Endometrial Carcinoma Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Molecular Diagnosis of Endometrial Carcinoma Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Molecular Diagnosis of Endometrial Carcinoma Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Molecular Diagnosis of Endometrial Carcinoma Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Molecular Diagnosis of Endometrial Carcinoma Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Molecular Diagnosis of Endometrial Carcinoma Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Molecular Diagnosis of Endometrial Carcinoma Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Molecular Diagnosis of Endometrial Carcinoma Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Molecular Diagnosis of Endometrial Carcinoma Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Molecular Diagnosis of Endometrial Carcinoma Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Molecular Diagnosis of Endometrial Carcinoma Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Molecular Diagnosis of Endometrial Carcinoma Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Molecular Diagnosis of Endometrial Carcinoma Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Molecular Diagnosis of Endometrial Carcinoma Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Molecular Diagnosis of Endometrial Carcinoma Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Molecular Diagnosis of Endometrial Carcinoma Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Molecular Diagnosis of Endometrial Carcinoma Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Molecular Diagnosis of Endometrial Carcinoma Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Molecular Diagnosis of Endometrial Carcinoma Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Molecular Diagnosis of Endometrial Carcinoma Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Molecular Diagnosis of Endometrial Carcinoma Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Molecular Diagnosis of Endometrial Carcinoma Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Molecular Diagnosis of Endometrial Carcinoma Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Molecular Diagnosis of Endometrial Carcinoma Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Molecular Diagnosis of Endometrial Carcinoma Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Molecular Diagnosis of Endometrial Carcinoma Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Molecular Diagnosis of Endometrial Carcinoma Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Molecular Diagnosis of Endometrial Carcinoma Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Molecular Diagnosis of Endometrial Carcinoma Market Size by Country (2022-2027) & (US$ Million)
Table 63. Inmedi Company Details
Table 64. Inmedi Business Overview
Table 65. Inmedi Molecular Diagnosis of Endometrial Carcinoma Product
Table 66. Inmedi Revenue in Molecular Diagnosis of Endometrial Carcinoma Business (2016-2021) & (US$ Million)
Table 67. Inmedi Recent Development
Table 68. United Gene Group Company Details
Table 69. United Gene Group Business Overview
Table 70. United Gene Group Molecular Diagnosis of Endometrial Carcinoma Product
Table 71. United Gene Group Revenue in Molecular Diagnosis of Endometrial Carcinoma Business (2016-2021) & (US$ Million)
Table 72. United Gene Group Recent Development
Table 73. Topgen Company Details
Table 74. Topgen Business Overview
Table 75. Topgen Molecular Diagnosis of Endometrial Carcinoma Product
Table 76. Topgen Revenue in Molecular Diagnosis of Endometrial Carcinoma Business (2016-2021) & (US$ Million)
Table 77. Topgen Recent Development
Table 78. Gene+ Company Details
Table 79. Gene+ Business Overview
Table 80. Gene+ Molecular Diagnosis of Endometrial Carcinoma Product
Table 81. Gene+ Revenue in Molecular Diagnosis of Endometrial Carcinoma Business (2016-2021) & (US$ Million)
Table 82. Gene+ Recent Development
Table 83. Sanvalley Company Details
Table 84. Sanvalley Business Overview
Table 85. Sanvalley Molecular Diagnosis of Endometrial Carcinoma Product
Table 86. Sanvalley Revenue in Molecular Diagnosis of Endometrial Carcinoma Business (2016-2021) & (US$ Million)
Table 87. Sanvalley Recent Development
Table 88. BGHDL Company Details
Table 89. BGHDL Business Overview
Table 90. BGHDL Molecular Diagnosis of Endometrial Carcinoma Product
Table 91. BGHDL Revenue in Molecular Diagnosis of Endometrial Carcinoma Business (2016-2021) & (US$ Million)
Table 92. BGHDL Recent Development
Table 93. Homey Health Company Details
Table 94. Homey Health Business Overview
Table 95. Homey Health Molecular Diagnosis of Endometrial Carcinoma Product
Table 96. Homey Health Revenue in Molecular Diagnosis of Endometrial Carcinoma Business (2016-2021) & (US$ Million)
Table 97. Homey Health Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Molecular Diagnosis of Endometrial Carcinoma Market Share by Type: 2020 VS 2027
Figure 2. PCR Features
Figure 3. FISH Features
Figure 4. DNA Sequencing Features
Figure 5. Gene Chip Features
Figure 6. Global Molecular Diagnosis of Endometrial Carcinoma Market Share by Application: 2020 VS 2027
Figure 7. Clinical Diagnosis Case Studies
Figure 8. Drug Screening Case Studies
Figure 9. Research Case Studies
Figure 10. Molecular Diagnosis of Endometrial Carcinoma Report Years Considered
Figure 11. Global Molecular Diagnosis of Endometrial Carcinoma Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Molecular Diagnosis of Endometrial Carcinoma Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Molecular Diagnosis of Endometrial Carcinoma Market Share by Regions: 2020 VS 2027
Figure 14. Global Molecular Diagnosis of Endometrial Carcinoma Market Share by Regions (2022-2027)
Figure 15. Global Molecular Diagnosis of Endometrial Carcinoma Market Share by Players in 2020
Figure 16. Global Top Molecular Diagnosis of Endometrial Carcinoma Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Molecular Diagnosis of Endometrial Carcinoma as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Molecular Diagnosis of Endometrial Carcinoma Revenue in 2020
Figure 18. Global Molecular Diagnosis of Endometrial Carcinoma Revenue Market Share by Type (2016-2021)
Figure 19. Global Molecular Diagnosis of Endometrial Carcinoma Revenue Market Share by Type (2022-2027)
Figure 20. North America Molecular Diagnosis of Endometrial Carcinoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Molecular Diagnosis of Endometrial Carcinoma Market Share by Type (2016-2027)
Figure 22. North America Molecular Diagnosis of Endometrial Carcinoma Market Share by Application (2016-2027)
Figure 23. North America Molecular Diagnosis of Endometrial Carcinoma Market Share by Country (2016-2027)
Figure 24. United States Molecular Diagnosis of Endometrial Carcinoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Molecular Diagnosis of Endometrial Carcinoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Molecular Diagnosis of Endometrial Carcinoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Molecular Diagnosis of Endometrial Carcinoma Market Share by Type (2016-2027)
Figure 28. Europe Molecular Diagnosis of Endometrial Carcinoma Market Share by Application (2016-2027)
Figure 29. Europe Molecular Diagnosis of Endometrial Carcinoma Market Share by Country (2016-2027)
Figure 30. Germany Molecular Diagnosis of Endometrial Carcinoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Molecular Diagnosis of Endometrial Carcinoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Molecular Diagnosis of Endometrial Carcinoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Molecular Diagnosis of Endometrial Carcinoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Molecular Diagnosis of Endometrial Carcinoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Molecular Diagnosis of Endometrial Carcinoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Molecular Diagnosis of Endometrial Carcinoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Molecular Diagnosis of Endometrial Carcinoma Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Molecular Diagnosis of Endometrial Carcinoma Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Molecular Diagnosis of Endometrial Carcinoma Market Share by Region (2016-2027)
Figure 40. China Molecular Diagnosis of Endometrial Carcinoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Molecular Diagnosis of Endometrial Carcinoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Molecular Diagnosis of Endometrial Carcinoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Molecular Diagnosis of Endometrial Carcinoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Molecular Diagnosis of Endometrial Carcinoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Molecular Diagnosis of Endometrial Carcinoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Molecular Diagnosis of Endometrial Carcinoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Molecular Diagnosis of Endometrial Carcinoma Market Share by Type (2016-2027)
Figure 48. Latin America Molecular Diagnosis of Endometrial Carcinoma Market Share by Application (2016-2027)
Figure 49. Latin America Molecular Diagnosis of Endometrial Carcinoma Market Share by Country (2016-2027)
Figure 50. Mexico Molecular Diagnosis of Endometrial Carcinoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Molecular Diagnosis of Endometrial Carcinoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Molecular Diagnosis of Endometrial Carcinoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Molecular Diagnosis of Endometrial Carcinoma Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Molecular Diagnosis of Endometrial Carcinoma Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Molecular Diagnosis of Endometrial Carcinoma Market Share by Country (2016-2027)
Figure 56. Turkey Molecular Diagnosis of Endometrial Carcinoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Molecular Diagnosis of Endometrial Carcinoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Molecular Diagnosis of Endometrial Carcinoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Inmedi Revenue Growth Rate in Molecular Diagnosis of Endometrial Carcinoma Business (2016-2021)
Figure 60. United Gene Group Revenue Growth Rate in Molecular Diagnosis of Endometrial Carcinoma Business (2016-2021)
Figure 61. Topgen Revenue Growth Rate in Molecular Diagnosis of Endometrial Carcinoma Business (2016-2021)
Figure 62. Gene+ Revenue Growth Rate in Molecular Diagnosis of Endometrial Carcinoma Business (2016-2021)
Figure 63. Sanvalley Revenue Growth Rate in Molecular Diagnosis of Endometrial Carcinoma Business (2016-2021)
Figure 64. BGHDL Revenue Growth Rate in Molecular Diagnosis of Endometrial Carcinoma Business (2016-2021)
Figure 65. Homey Health Revenue Growth Rate in Molecular Diagnosis of Endometrial Carcinoma Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
世界の鼻咽頭癌分子診断市場規模・現状・予測（2021年-2027年） A molecular approach for diagnosing nasopharyngeal carcinoma Market Analysis and Insights: Global Molecular Diagnosis of Nasopharyngeal Carcinoma Market The global Molecular Diagnosis of Nasopharyngeal Carcinoma market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, a…- 世界の骨髄異形成症候群分子診断市場規模・現状・予測（2021年-2027年） A diagnostic method for myelodysplastic syndrome Market Analysis and Insights: Global Molecular Diagnosis of Myelodysplastic Syndrome Market The global Molecular Diagnosis of Myelodysplastic Syndrome market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of …
- 世界の口腔がん分子診断市場規模・現状・予測（2021年-2027年） A molecular approach for diagnosing oral cancer Market Analysis and Insights: Global Oral Cancer Molecular Diagnosis Market The global Oral Cancer Molecular Diagnosis market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With indust…
- 世界の胆嚢がん分子診断市場規模・現状・予測（2021年-2027年） A method for diagnosing gallbladder cancer Market Analysis and Insights: Global Molecular Diagnosis of Gallbladder Cancer Market The global Molecular Diagnosis of Gallbladder Cancer market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-20…
- 世界の遺伝性大腸がん分子診断市場規模・現状・予測（2021年-2027年） A method for diagnosing hereditary colorectal cancer Market Analysis and Insights: Global Molecular Diagnosis of Hereditary Colorectal Cancer Market The global Molecular Diagnosis of Hereditary Colorectal Cancer market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, a…